Process for producing crystal

Details Process for producing crystal Process for producing crystal

2011-08-09

2011-08-09

Chandrakumar, Nizal (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07994332

ABSTRACT:
The present invention relates to a production method of a crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole.n′H2O (wherein n′ is about 0 to about 0.1) or a salt thereof, which characteristically includes crystallization from an organic solvent solution or suspension in which (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-benzimidazole.nH2O (wherein n is about 0.1 to about 1.0) or a salt thereof has been dissolved or suspended, and the like, and provides a convenient method for efficiently producing an optically active sulfoxide derivative having an extremely high enantiomer excess in high yield at an industrial large scale.

REFERENCES:
patent: 4628098 (1986-12-01), Nohara
patent: 6002011 (1999-12-01), Kato et al.
patent: 6462058 (2002-10-01), Fujishima et al.
patent: 6664276 (2003-12-01), Fujishima et al.
patent: 7169799 (2007-01-01), Hashimoto et al.
patent: 2007/0265335 (2007-11-01), Liu et al.
patent: 1223262 (1999-07-01), None
patent: 0 302 720 (1989-02-01), None
patent: 0 174 726 (1996-03-01), None
patent: 1 191 025 (2002-03-01), None
patent: 92/08716 (1992-05-01), None
patent: 96/02535 (1996-02-01), None
patent: 96/17077 (1996-06-01), None
patent: 97/02261 (1997-01-01), None
patent: 98/21201 (1998-05-01), None
patent: 98/28294 (1998-07-01), None
patent: 99/38512 (1999-08-01), None
patent: 99/38513 (1999-08-01), None
patent: 00/78745 (2000-12-01), None
patent: 02/44167 (2002-06-01), None
Borner, et al., “Separation of Lansoprazole Enantiomers in Human Serum by HPLC”, Chromatographia vol. 47, No. 3/4, Feb. 1998, pp. 171-175.
Arimori, et al., “Pharmacokinetic Differences Between Lansoprazole Enantiomers in Rats”, J. Pharm. Pharmacol., vol. 50, No. 11, 1998, pp. 1241-1245.
Haleblian, et al., “Pharmaceutical Applications of Polymorphism”, Journal of Pharmaceutical Sciences, vol. 58, No. 8. Aug. 1969, pp. 911-929.
Caira, “Crystalline Polymorphism of Organic Compounds”, Topics in Current Chemistry, vol. 198, 1998, pp. 164-208.
Gennaro, ed., Remington: The Science and Practice of Pharmacy, 20thEd. Baltimore, USA:Lippincott Williams & Wilkins, Chapter 38, 2000, pp. 702-711.
U.S. Pharmacopeia #23, National Formulatory #18 (1995), pp. 1843 and 1844.
Concise Encyclopedia Chemistry, Translated and revised by Mary Eagleson (1994), Walter de Gruyter: New York, pp. 872 and 87.
Rouhi, A. Maureen, “The Right Stuff”, C & E News (Feb. 24, 2003), pp. 32-35.
Curin, A. Sitar, “Study of Crystal Modifications of Lansoprazole using FT-IR . . .” The Second Central European Symposium on Pharmaceutical Technology (1997), pp. 290-291.
Vrecer, F. et al., “Study of Influence of Temperature and Griding on the . . .” The Second Central European Symposium on Pharmaceutical Technology (1997), pp. 242 and 243.
Katsuki, H. et al., “Determination of R(+)- and S(−)-Lansoprazole Using Chiral Stationalry-Phase Liquid . . .”, Pharmaceutical Research, vol. 13, No. 4, (1996), pp. 611-615.
Nagaya, H., et al., “Effects of the Enantiomers of Lansoprazole (AG-1749) . . .”, Biochemical Pharmacology, vol. 42, No. 10 (1991), pp. 1875-1878.
“Experimental Chemistry: Organic Reactions”, JP Document and English Translation, vol. 18, published May 23, 1957.

Affiliated with

Also associated with

Rating

Process for producing crystal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for producing crystal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing crystal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2784363